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Upper tract urothelial carcinoma (UTUC) of the kidney and
ureter is a rare neoplasm with roughly 3000 cases diagnosed
in the United States in 2007, compared to approximately
67000 cases of bladder cancer. UTUC accounts for approx-
imately 10% of cancers arising from the kidney and less
than 5% of all urothelial malignancies. Predominantly due
to the rarity of the disease, there is only limited data to
guide clinicians in decision making which consists mostly
of small retrospective studies and expert opinion. As such,
this special issue of Advances in Urology “Comprehensive
Management of Upper Tract Urothelial Carcinoma” focuses
b o t ho nc o n t r o v e r s i e si nm a n a g e m e n ta sw e l la sp r a c t i c a l
issuesinthecareofpatientswithUTUC.AstheGuestEditor,
mygoalhasbeentoaskaseriesofquestionsandseekanswers
from international experts in the ﬁeld.
The ﬁrst practical matter is to address when endoscopic
management of UTUC is appropriate? Our ﬁrst article
“Endoscopic Management of Upper Tract Urothelial Carci-
noma” by Katie Moore et al. addresses this issue generally.
Then, the paper entitled “Endourologic Management of
Upper Tract Transitional Cell Carcinoma Following Cystec-
tomy and Urinary Diversion” by Jeﬀrey John Tomaszewski
et al. tackles the diﬃcult situation of UTUC after radical
cystectomy and urinary diversion. Finally, after initial endo-
scopic management of UTUC, what is the role of upper tract
topicalchemotherapyorBCG?Thistopicisthesubjectofthe
paper entitled “Review of Topical Treatment of Upper Tract
Urothelial Carcinoma” by Kenneth G. Nepple et al.
The next issue of focus is the clinical scenario when
UTUC cannot be managed endoscopically. Are laparoscopic
and open nephroureterectomy equivalent operations? What
is the best way to handle the distal ureter and bladder
cuﬀ? These challenging topics are addressed by a series
of articles: “Laparoscopic Nephroureterectomy: Oncologic
Outcomes and Management of Distal Ureter: Review of the
Literature” by Andre Berger and Amr Fergany, “Laparo-
scopic Nephroureterectomy: The Distal Ureteral Dilemma”
by Shalom Srirangam et al., as well as “Laparoscopic
Nephroureterectomy and Management of the Distal Ureter:
A Review of Current Techniques and Outcomes” by Davis
Viprakasit et al. Regardless of open versus laparoscopic
approaches to nephroureterectomy, what is the role and
extent of lymphadenectomy in the management of UTUC?
This critical issue is dealt with in the paper entitled
“Retroperitoneal Lymph Nodes in Transitional Cell Carci-
noma of the Kidney and Ureter” by Shilajit D. Kundu and
Scott E. Eggener.
Thelastmatteristhemanagementofpatientswithlocally
advanced or metastatic UTUC. Is there a role for adjuvant
chemotherapy? What are the best agents for metastatic
UTUC? Can data from bladder cancer be applied to the
upper tracts? These timely topics are concentrated upon
in the article “The Role of Chemotherapy in Upper Tract
Urothelial Carcinoma” by Peter H ODonnell and Walter M.
Stadler. Finally, these various issues are brought together and
placed into perspective in the review entitled “Comprehen-
sive Management of Upper Tract Urothelial Carcinoma” by
Georgios Koukourakis et al.
It has been my privilege to serve as the Guest Editor for
this special issue of Advances in Urology “Comprehensive
Management of Upper Tract Urothelial Carcinoma.”
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